Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
0.906 USD | -4.63% | -5.24% | -13.36% |
01/04 | Quince Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
26/03 | Transcript : Quince Therapeutics, Inc. - Special Call |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration1st Jan change | Capi. | |
---|---|---|
-13.36% | 41.05M | |
+26.08% | 44.96B | |
-0.74% | 42.65B | |
+46.00% | 41.85B | |
-5.31% | 29.04B | |
+9.52% | 26.08B | |
-21.48% | 19.03B | |
+6.12% | 12.75B | |
+27.59% | 12.06B | |
-3.32% | 11.75B |
- Stock Market
- Equities
- QNCX Stock
- News Quince Therapeutics, Inc.
- Citigroup Adjusts Cortexyme's Price Target to $2 From $5, Maintains Sell Rating